RxDoctor Payments Data

Rajendra Bhayani, MD

Facial Plastic Surgery · Brooklyn, NYNPI 1467491423

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Boston Scientific at 40.7% of the total. Reporting peaked in 2019 at $572 and has fallen 66.3% since, to $193 in 2025. That places this record below the midpoint for facial plastic surgery clinicians in NY, where the typical reported total is $1,459.

$1,566in general payments, 2019–2025

Across 20 payments — averaging $78.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$637
  • Stryker$442
  • Amgen$125
  • Rigel Pharmaceuticals, Inc.$125
  • Novo Nordisk$123
  • Lilly USA, LLC$80
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$1,566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,566 in reported general payments places this provider in the 50th percentile of 48 facial plastic surgery providers in New York.

See all facial plastic surgery providers in New York

Medicare billing

Part B allowed, 2024
$332,751
Medicare patients
302
Services billed
6,800

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate919$7,640
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort49$2,301
CefuroximeCefuroxime Axetil127$1,822
Omeprazole277$1,732
Mometasone Furoate94$1,521
Chlorhexidine Gluconate151$559
Ipratropium Bromide12$395
Meclizine Hcl58$380
Prednisone142$263
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen50$185
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$181
Ibuprofen26$104
Acetaminophen-CodeineAcetaminophen With Codeine23$93
Levofloxacin20$49

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →